The agreement with Algen Biotechnologies gives AstraZeneca exclusive rights to develop and commercialise therapies from the ...

MIT researchers have dramatically lowered the error rate of prime editing, a technique with promise for treating numerous ...

Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct ...

Researchers have introduced a new analytical approach that could improve the interpretation of genetic variation in ...

Researchers from the Department of Biomedical Engineering at UNIST and the Center for Genomic Integrity at the Institute for Basic Science (IBS) have announced an advance in cancer gene therapy. Their ...

Cayman Chemical, a global provider of life science research tools, and Akadeum Life Sciences, a leader in buoyancy-based cell ...

UCSF researchers tested CRISPRa, a gentler form of gene editing, in mice with a rare brain disorder caused by a faulty SCN2A gene. By boosting the healthy copy of the gene, the treatment restored ...

Microorganisms produce a wide variety of natural products that can be used as active ingredients to treat diseases such as infections or cancer. The blueprints for these molecules can be found in the ...

This story is part of a series on the current progression in Regenerative Medicine. In 1999, I defined regenerative medicine as the collection of interventions that restore tissues and organs damaged ...

Biotech company Factor Bioscience sued rival Cellectis and pharmaceutical giant AstraZeneca in Delaware federal court on ...